14^th Global Biomarkers Summit October18-19,2018 | Amsterdam, Netherlands

Dr. Lee obtained his PhD in Statistics at the University of Wisconsin at Madison. He then completed postdoctoral training in computational biology and statistical genetics at the University of Southern California and worked as a Research Scientist in the Laboratory of Molecular Pharmacology at the National Cancer Institute (NCI). Prior to joining Moffitt, he had then worked as Professor and Director of Biostatistics at the University of Virginia School of Medicine. His expertise is in biostatistics and biomedical informatics with a focus on personalized medicine and predictive biomarker developments in ovarian, breast and other cancers.

Biostatistics and Bioinformatics, Chemical Biology ,Molecular Medicine, Computational Statistics & Statistical Genetics

Kenji Suzuki, Ph.D. (by Published Work; Nagoya University) worked at Hitachi Medical Corporation, Japan, Aichi Prefectural University, Japan, as a faculty member, and in Department of Radiology, University of Chicago, as Assistant Professor. In 2014, he joined Department of Electric and Computer Engineering and Medical Imaging Research Center, Illinois Institute of Technology, as Associate Professor. Since 2017, he has been jointly appointed in World Research Hub Initiative at Tokyo Institute of Technology, Japan, as Full Professor (Specially Appointed). He published more than 320 papers (including 110 peer-reviewed journal papers). He is inventor on 30 patents (including 13 granted patents), which were licensed to several companies and commercialized. He published 10 books and 22 book chapters, and edited 13 journal special issues. He was awarded/co-awarded more than 25 grants as PI including NIH R01 and ACS. He served as the Editor of a number of leading international journals, including Pattern Recognition and Medical Physics. He served as a referee for 83 international journals, an organizer of 35 international conferences, and a program committee member of 150 international conferences. He received 25 awards.

Deep learning, machine learning, computer-aided diagnosis, medical image processing, medical image analysis, and artificial intelligence

Dr. Pant received his M.A. and Ph.D. degrees in Physics from Agra University, Agra, India. His postdoctoral studies were conducted on the mechanisms of electron and ion transport in model membrane systems at the Department of Biophysics at Michigan State University. He joined the Laboratory of Neurobiology in the NIMH as a senior staff fellow in 1974 with Dr. Ichiji Tasaki where he studied the function of the axonal cytoskeleton in the squid giant axon. In 1979 he moved to the NIAAA extending his studies on the neuronal cytoskeleton and the effects of alcohol on its regulation. Dr. Pant moved to the NINDS, Laboratory of Neurochemistry in 1987 where he is presently chief of the section on Cytoskeleton Regulation. His laboratory is studying the mechanisms of topographic regulation of neuronal cytoskeleton proteins by post-translational modification, including the role of kinase cascades in normal brain and during neurodegeneration.

Mechanisms of topographic regulation of neuronal cytoskeletal proteins regulation by phosphorylation and neurodegeneration

Dimitrios H. Roukos, MD, Ph.D., is Professor of Surgery – Precision Cancer Medicine and Founding director of “Centre for Biosystems and Genome Network Medicine” in the Ioannina University, School of Medicine. His translational and clinical research from traditional and single gene investigation to molecular networks and clinical cancer genome NGS analysis has been recognized by the international scientific community. He has published > 236 PubMed papers with recent focus on NGS conventional and breakthrough genome analysis (> 80 articles) and more recently in precision cancer medicine (31 articles). These publications have received more than 8420 citations with h-index: 72 (Scopus). He is a reviewer in many high impact journals including some with impact factor (IF) >30, evaluator in innovative research projects (EU, France, Belgium, Luxemburg, Poland), and member in the editorial board of 25 international journals with IF. He has been invited as a speaker in many international and world congresses

Cancer genome analysis applying Next - Generation Sequencing, molecular interactions regulatory networks and nonlinear transcriptional biocircuits for clinical implications

Prof. Dr. Jan Jacques Michiels Multidisciplinairy Internist Blood Coagulation & Vascular Medicine Center, CEO and Founder of Goodheart Institute in Nature Medicine & Health, Founder and Editor in Chief World Journal of Vascular Medicine: WJVM, Editor in chief Journal of Hematology and Thromboembolic Diseases, Editor of World Journal of Hematology: WJH. Senior Scientific Advisor European Leukemia-Net MPN, Mannheim, European Community, Brussels, Visiting professor Blood & Coagulation Disorders Depts of Hematology of the University Hospital Antwerp, Belgium, University Brno, Czech Republic and Colentina University Hospital, Bucharest, Romania. Prof. Dr. Jan Jacques Michiels is Consultant Professor Bloodcoagulation and Co-Founder of the Hememostasis Research Unit and Von Willebrand Research Laboratory, University Hospital Antwerp, Belgium. Founder International Collaboration and Research in MPN: ICAR; MPN within the European Leukemia-Network: ELN. He is a CoFounder of the Central European Vascular. He is Expert member Leukemia Net, Mannheim, Gernamy (Chair & Founder ELN, Professor Hehlmann, Mannheim). Founder International Collaborations & Academic Research on Von Willebranf Factor and Von Willebrand Disease: ICAR:VWF-VDW. Prof. Dr. Jan Jacques Michiels served as Guest Editor of many of the International Journals in Hematology, Hemostasis, Thrombosis and Vascular Medicine.

Leukemia, Hematology and Thromboembolic Diseases, Haemostasis, Bool & Coagulation Disorders

Dr Kerr was appointed an Early Detection Programme Manager at Cancer Research UK in 2016. She is responsible for managing a biomarker discovery programme and initiatives to improve industry engagement and the translation of diagnostics. In 2014, she completed a PhD at Monash University in Melbourne, Australia, examining ErbB4 splice variants as biomarkers and/or molecular targets in glioblastoma. Following this, she completed a Post-Doctoral position imaging respiratory disease in vivo at Synchrotrons in Australia and Japan.

Early detection and diagnosis, biomarker discovery and validation, diagnostic biomarkers, oncology, diagnostic development, screening

Dr. Wassil Nowicky — Dipl. Ing., Dr. techn., DDDr. h. c., Director of “Nowicky Pharma” and President of the Ukrainian Anti-Cancer Institute (Vienna, Austria). Has finished his study at the Radiotechnical Faculty of the Technical University of Lviv (Ukraine) with the end of 1955 with graduation to “Diplomingeniueur” in 1960 which title was nostrificated in Austria in 1975. Dr. Wassil Nowicky became the very first scientist in the development of the anticancer protonic therapy and is the inventor of the preparation against cancer with a selective effect on basis of celandine alkaloids “NSC-631570”. He used the factor that cancer cells are more negative charged than normal cells and invented the Celandine alkaloid with a positive charge thanks to which it accumulates in cancer cells very fast. Thus, Dr. Nowicky is invited as an Honorable Speaker to take part in many scientific international congresses and conferences in USA, Australia, Japan, UAE, Europe. Author of over 300 scientific articles dedicated to cancer research. Dr. Wassil Nowicky is a real member of the New York Academy of Sciences, member of the European Union for applied immunology and of the American Association for scientific progress, honorary doctor of the Janka Kupala University in Hrodno, doctor “honoris causa” of the Open international university on complex medicine in Colombo, honorary member of the Austrian Society of a name od Albert Schweizer. He has received the award for merits of National guild of pharmasists of America. the award of Austrian Society of sanitary, hygiene and public health services and others.

Heart Disease Research ,Acupuncture & Electro-Therapeutics Research, Integrated Medicine

Youhe Gao is a Professor in Beijing Normal University. He received his MD from Peking Union Medical College and his from PhD from University of Connecticut and Postdoctoral training from Beth Israel Deaconess Medical Center, Harvard Medical School. He was the Professor of Department of Pathophysiology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences/ Peking Union Medical College from 2001-2014. His research interests include biomarker discovery in urine, urine biobanking, protein interaction methods and related bioinformatics.

Pathophysiology, Biomarkers, Bioinformatics, Biobanking.

Zeliha Selamoglu is a Professor in Medical Biology department of Nigde Ömer Halisdemir University, Turkey. She earned her PhD in Biology from Inonu University, She has published over 90 peerreviewed journal articles with over 800 citations and many technical reports. She is a member of Society for Experimental Biology and Medicine: Associate Membership and European association for cancer research. She has served as Editorial Board member for many Journals. h-index: 14 citations: 810

Medical Biology, Molecular Biology, Biochemistry, Biotechnology, Oxidative stress, Antioxidants, Cancer.

Kaushala Prasad Mishra has earned B.Sc and M.Sc. degrees from Allahabad University and Ph.D. from Gujarat University. His areas of Specialization: Life Sciences, Radiation Biology, Biotechnology, Biophysics and chemistry. He has been Research Guide for Ph.D. students in many Universities of India; Successfully guided 41 Ph.D. students and presently guiding 08 students. He has published more than 280 research papers and proceeding papers in National and International Journals. He has delivered more than 300 invited talks in Symposia and Conferences. He is currently the Vice Chancellor of Nehru Gram Bharati University, Allahabad, India. He also served as Head, Radiation Biology and Health Science Division and Senior Scientific Officer of Bhabha Atomic Research Center, Department of Atomic Energy, and Government of India, Chairman, Standing Selection Committee, Member, Trombay Scientific Council, BARC, Member, Health, Safety & Biomedical Group Board, Member, Committee of Atomic Energy Commission on Health and Environment Aspects of Uranium Mining at Jaduguda, Member, Core Expert Group on Chemical Disaster and Nuclear Disaster Management of National Disaster Management Authotrity of India (NDMA). He served as Chancellor's Nominee in Selection Committees of Padmashri Dr. D.Y. Patil Deemed University; Mumbai and West Bengal University of Technology, Kolkata and served as Expert on Selection Committees of IITs and several Universities in India.

Life Sciences, Radiation Biology, Biotechnology, Biophysics and Chemistry